Abstract:Introduction: Insufficient tumor permeability and inadequate nanoparticle retention continue to be significant limitations in the efficacy of anti-tumor drug therapy. Numerous studies have focused on enhancing tumor perfusion by improvement of tumor-induced endothelial leakage, often known as the enhanced permeability and retention (EPR) effect. However, these approaches have produced suboptimal therapeutic outcomes and have been associated with significant side effects. Therefore, in this study, we prepared tumor cell membrane-coated gold nanorods (GNR@TM) to enhance drug delivery in tumors through homogeneous targeting of tumor cell membranes and in situ real-time photo-controlled therapy. Methods: Here, we fabricated GNR@TM, and characterized it using various techniques including Ultraviolet-Visible (UV-Vis) spectrophotometer, particle size analysis, potential measurement, and transmission electron microscopy (TEM). The cellular uptake and cytotoxicity of GNR@TM were analyzed by flow cytometry, confocal laser scanning microscopy (CLSM), TEM, CCK8 assay and live/dead staining. Tissue drug distribution was determined by inductively coupled plasma mass spectrometry (ICP-MS) and immunofluorescence staining. Furthermore, to evaluate the therapeutic effect, mice bearing MB49 tumors were intravenously administered with GNR@TM. Subsequently, near-infrared (NIR) laser therapy was performed, and the mice's tumor growth and body weight were monitored. Results: The tumor cell membrane coating endowed GNR@TM with extended circulation time in vivo and homotypic targeting to tumor, thereby enhancing the accumulation of GNR@TM within tumors. Upon 780 nm laser, GNR@TM exhibited excellent photothermal conversion capability, leading to increased tumor vascular leakage. This magnification of the EPR effect induced by NIR laser further increased the accumulation of GNR@TM at the tumor site, demonstrating strong antitumor effects in vivo. Conclusion: In this study, we successfully developed a NIR-triggered nanomedicine that increased drug accumulation in tumor through photo-controlled therapy and homotypic targeting of the tumor cell membrane. GNR@TM has been demonstrated effective suppression of tumor growth, excellent biocompatibility, and significant potential for clinical applications.

The Passive Targeting of Polymeric Micelles in Various Types and Sizes of Tumor Models

Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer

From combinatorial chemistry to cancer targeting nanotherapeutics

A Novel Size-Tunable Nanocarrier System for Targeted Anticancer Drug Delivery

Tumor-Targeting Micelles Based on Linear Dendritic PEG-PTX8 Conjugate for Triple Negative Breast Cancer Therapy

DOX-encapsulated intelligent PAA-g-PEG/PEG–Fa polymeric micelles for intensifying antitumor therapeutic effect via active-targeted tumor accumulation

Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes

Polymeric Micelles for Tumor Theranostics

Polymeric Micelles for Enhanced Lymphatic Drug Delivery to Treat Metastatic Tumors.

Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging

Solid Tumor Penetration by Integrin-Mediated Pegylated Poly(trimethylene Carbonate) Nanoparticles Loaded with Paclitaxel.

Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting

In Vivo Therapeutic Evaluation of Polymeric Nanomedicines: Effect of Different Targeting Peptides on Therapeutic Efficacy Against Breast Cancer

Bioreducible Paa-G-Peg Graft Micelles with High Doxorubicin Loading for Targeted Antitumor Effect Against Mouse Breast Carcinoma

Combinatorial Targeting Polymeric Micelles for Anti-Tumor Drug Delivery.

Poly(Ethylene Glycol)-Polylactide Micelles For Cancer Therapy

Enhancing the Accumulation of Polymer Micelles by Selectively Dilating Tumor Blood Vessels with NO for Highly Effective Cancer Treatment.

Correlation of polymeric micelle sizes and their cellular internalization in vitro and tumor targeting in vivo

Promoting Intratumoral Drug Accumulation by Bio-Membrane Regulated Active Targeting for Tumor Photothermal Therapy

An NIR-Guided Aggregative and Self-Immolative Nanosystem for Efficient Cancer Targeting and Combination Anticancer Therapy.

Using PEGylated Magnetic Nanoparticles to Describe the EPR Effect in Tumor for Predicting Therapeutic Efficacy of Micelle Drugs